4.8 Article

Yeast Smy2 and its human homologs GIGYF1 and-2 regulate Cdc48/VCP function during transcription stress

Journal

CELL REPORTS
Volume 41, Issue 4, Pages -

Publisher

CELL PRESS
DOI: 10.1016/j.celrep.2022.111536

Keywords

-

Categories

Funding

  1. Francis Crick Institute
  2. Cancer Research UK [FC001166]
  3. UK Medical Research Council
  4. Wellcome Trust
  5. European Research Council [693327]
  6. Novo Nordisk Foundation [NNF19OC0055875]
  7. Danish National Research Foundation [DNRF153]

Ask authors/readers for more resources

The SMY2 gene and its homologs GIGYF1 and GIGYF2 play crucial regulatory roles in the transcription stress response, affecting the function of key factors such as Cdc48/VCP/p97.
The last resort pathway results in ubiquitylation and degradation of RNA polymerase II in response to transcription stress and is governed by factors such as Def1 in yeast. Here, we show that the SMY2 gene acts as a multi-copy suppressor of DEF1 deletion and functions at multiple steps of the last resort pathway. We also provide genetic and biochemical evidence from disparate cellular processes that Smy2 works more broadly as a hitherto overlooked regulator of Cdc48 function. Similarly, the Smy2 homologs GIGYF1 and-2 affect the transcription stress response in human cells and regulate the function of the Cdc48 homolog VCP/p97, presently being explored as a target for cancer therapy. Indeed, we show that the apoptosis-inducing effect of VCP inhibitors NMS-873 and CB-5083 is GIGYF1/2 dependent.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available